The emerging role of non-coding RNAs in the Wnt/β-catenin signaling pathway in Prostate Cancer.

[1]  P. Prasher,et al.  From carcinogenesis to therapeutic avenues: lncRNAs and mTOR crosstalk in lung cancer. , 2023, Pathology, research and practice.

[2]  Imran Kazmi,et al.  Unwinding circular RNA's role in inflammatory pulmonary diseases. , 2023, Naunyn-Schmiedeberg's archives of pharmacology.

[3]  W. Almalki,et al.  HOTAIR: A key regulator of the Wnt/β-catenin signaling cascade in cancer progression and treatment. , 2023, Pathology, research and practice.

[4]  Imran Kazmi,et al.  From LncRNA to metastasis: The MALAT1-EMT axis in cancer progression. , 2023, Pathology, research and practice.

[5]  Sami I. Alzarea,et al.  Exploring the role of lncrna neat1 knockdown in regulating apoptosis across multiple cancer types: A review. , 2023, Pathology, research and practice.

[6]  N. Altwaijry,et al.  The complex role of MEG3: An emerging long non-coding RNA in breast cancer. , 2023, Pathology, research and practice.

[7]  P. Lequerica-Fernández,et al.  Prognostic Significance of β-Catenin in Relation to the Tumor Immune Microenvironment in Oral Cancer , 2023, Biomedicines.

[8]  Gaurav Gupta,et al.  Uncovering the complex role of interferon-gamma in suppressing type 2 immunity to cancer. , 2023, Cytokine.

[9]  Gaurav Gupta,et al.  A comprehensive review on the emerging role of long non-coding RNAs in the regulation of NF-κB signaling in inflammatory lung diseases. , 2023, International journal of biological macromolecules.

[10]  Li Zhou,et al.  Epstein-Barr virus-encoded miR-BART11-3p modulates the DUSP6-MAPK axis to promote gastric cancer cell proliferation and metastasis , 2023, Journal of virology.

[11]  Tingming Liang,et al.  Deciphering the Enigmatic Influence: Non-Coding RNAs Orchestrating Wnt/β-Catenin Signaling Pathway in Tumor Progression , 2023, International journal of molecular sciences.

[12]  X. Zhang,et al.  Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer , 2023, Cancer immunology research.

[13]  Gaurav Gupta,et al.  From nature to therapy: Luteolin's potential as an immune system modulator in inflammatory disorders , 2023, Journal of biochemical and molecular toxicology.

[14]  Gaurav Gupta,et al.  Unveiling the connection: Long-chain non-coding RNAs and critical signaling pathways in breast cancer. , 2023, Pathology, research and practice.

[15]  Sami I. Alzarea,et al.  Long non-coding RNAs in lung cancer: Unraveling the molecular modulators of MAPK signaling. , 2023, Pathology, research and practice.

[16]  Gaurav Gupta,et al.  Probing the links: Long non-coding RNAs and NF-κB signalling in atherosclerosis. , 2023, Pathology, research and practice.

[17]  Arvind Negi,et al.  Crosstalk between long noncoding RNA and microRNA in Cancer , 2023, Cellular Oncology.

[18]  Kefei Yuan,et al.  CircZNF215 promotes tumor growth and metastasis through inactivation of the PTEN/AKT pathway in intrahepatic cholangiocarcinoma , 2023, Journal of Experimental & Clinical Cancer Research.

[19]  C. Stief,et al.  Methylation status of various gene loci in localized prostate cancer: Novel biomarkers for diagnostics and biochemical recurrence. , 2023, Urologic oncology.

[20]  E. Abdelhay,et al.  Epigenetic Alterations in DCIS Progression: What Can lncRNAs Teach Us? , 2023, International journal of molecular sciences.

[21]  Liuqing Yang,et al.  Plumbing Mysterious RNAs in "Dark Genome" for the Conquest of Human Diseases. , 2023, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  F. Bray,et al.  2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review. , 2023, European urology.

[23]  Tiana Loan Young,et al.  Clinical Delivery of Circular RNA: Lessons Learned from RNA Drug Development. , 2023, Advanced drug delivery reviews.

[24]  Chunru Lin,et al.  Decoding the regulatory roles of non-coding RNAs in cellular metabolism and disease , 2023, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  Haifeng Zhang,et al.  The WNT/β-catenin system in chronic kidney disease-mineral bone disorder syndrome , 2023, International Urology and Nephrology.

[26]  J. Sluijter,et al.  Circular RNAs in Cardiovascular Diseases: Regulation and Therapeutic Applications , 2023, Research.

[27]  Howard Y. Chang,et al.  Long non-coding RNAs: definitions, functions, challenges and recommendations , 2023, Nature Reviews Molecular Cell Biology.

[28]  T. G. Singh,et al.  Biosimilars in Oncology: Latest Trends and Regulatory Status , 2022, Pharmaceutics.

[29]  Yue Li,et al.  Targeted OUM1/PTPRZ1 silencing and synergetic CDT/enhanced chemical therapy toward uveal melanoma based on a dual-modal imaging-guided manganese metal–organic framework nanoparticles , 2022, Journal of Nanobiotechnology.

[30]  D. Ferreira,et al.  Satellite Noncoding RNAs (ncRNA) as Cancer Biomarkers? New Insights from FA-SAT ncRNA Molecular and Clinical Profiles in Feline Mammary Tumors. , 2022, Omics : a journal of integrative biology.

[31]  S. Ramalingam,et al.  Influence of Long Non-Coding RNA in the Regulation of Cancer Stem Cell Signaling Pathways , 2022, Cells.

[32]  Hamid Behrouj,et al.  Exosomal noncoding RNAs in prostate cancer. , 2022, Clinica chimica acta; international journal of clinical chemistry.

[33]  Jianguo Feng,et al.  Non-Coding RNA Related to MAPK Signaling Pathway in Liver Cancer , 2022, International journal of molecular sciences.

[34]  M. Michalska,et al.  Analysis of Long Non-Coding RNA (lncRNA) UCA1, MALAT1, TC0101441, and H19 Expression in Endometriosis , 2022, International journal of molecular sciences.

[35]  D. Chellappan,et al.  Role of Medicinal plant-derived Nutraceuticals as a potential target for the treatment of breast cancer. , 2022, Journal of food biochemistry.

[36]  L. Kristensen,et al.  Non-coding RNAs and epithelial mesenchymal transition in cancer: molecular mechanisms and clinical implications , 2022, Journal of Experimental & Clinical Cancer Research.

[37]  G. Calin,et al.  Emerging role of oncogenic long noncoding RNA as cancer biomarkers , 2022, International journal of cancer.

[38]  G. Gupta,et al.  Targeting the mitochondria in chronic respiratory diseases. , 2022, Mitochondrion.

[39]  G. Gupta,et al.  The therapeutic role of nutraceuticals targeting the Nrf2/HO-1 signaling pathway in liver cancer. , 2022, Journal of food biochemistry.

[40]  R. Piergentili,et al.  Using ncRNAs as Tools in Cancer Diagnosis and Treatment—The Way towards Personalized Medicine to Improve Patients’ Health , 2022, International journal of molecular sciences.

[41]  M. Tripodi,et al.  Next RNA Therapeutics: The Mine of Non-Coding , 2022, International journal of molecular sciences.

[42]  Yundong He,et al.  Targeting signaling pathways in prostate cancer: mechanisms and clinical trials , 2022, Signal Transduction and Targeted Therapy.

[43]  Gene W. Yeo,et al.  Engineered U1 snRNAs to modulate alternatively spliced exons. , 2022, Methods.

[44]  Sami I. Alzarea,et al.  Sodium alginate based drug delivery in management of breast cancer. , 2022, Carbohydrate polymers.

[45]  François Bordeleau,et al.  The Extracellular Matrix Stiffening: A Trigger of Prostate Cancer Progression and Castration Resistance? , 2022, Cancers.

[46]  G. Calin,et al.  Non-coding RNAs and ferroptosis: potential implications for cancer therapy , 2022, Cell Death & Differentiation.

[47]  G. Calin,et al.  Targeting non-coding RNAs to overcome cancer therapy resistance , 2022, Signal Transduction and Targeted Therapy.

[48]  Sijun Deng,et al.  The Role of NcRNAs to Regulate Immune Checkpoints in Cancer , 2022, Frontiers in Immunology.

[49]  M. Negrini,et al.  Detection of disease‐causing mutations in prostate cancer by NGS sequencing , 2022, Cell biology international.

[50]  Ronghua Yang,et al.  Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration , 2022, Frontiers in immunology.

[51]  Fan Yang,et al.  Exosomal LINC01213 Plays a Role in the Transition of Androgen-Dependent Prostate Cancer Cells into Androgen-Independent Manners , 2022, Journal of oncology.

[52]  Yuzhuo Wang,et al.  The long and short non-coding RNAs modulating EZH2 signaling in cancer , 2022, Journal of Hematology & Oncology.

[53]  I. Gill,et al.  Trends in Incidence of Metastatic Prostate Cancer in the US , 2022, JAMA network open.

[54]  S. Ro,et al.  Current Advances in RNA Therapeutics for Human Diseases , 2022, International journal of molecular sciences.

[55]  Xian Zhang,et al.  SIRT6 Promotes the Progression of Prostate Cancer via Regulating the Wnt/β-Catenin Signaling Pathway , 2022, Journal of oncology.

[56]  S. Xia,et al.  The potential roles and mechanisms of non-coding RNAs in cancer anoikis resistance , 2022, Molecular and Cellular Biochemistry.

[57]  Lingjuan Zhu,et al.  Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy , 2022, Journal of Hematology & Oncology.

[58]  V. Meniel,et al.  Exploring the Wnt Pathway as a Therapeutic Target for Prostate Cancer , 2022, Biomolecules.

[59]  T. Shirota,et al.  Impact of Non-Coding RNAs on Chemotherapeutic Resistance in Oral Cancer , 2022, Biomolecules.

[60]  C. Fletcher,et al.  Crosstalk between Long Non Coding RNAs, microRNAs and DNA Damage Repair in Prostate Cancer: New Therapeutic Opportunities? , 2022, Cancers.

[61]  M. Gazouli,et al.  The Role of Exosomal Non-Coding RNAs in Colorectal Cancer Drug Resistance , 2022, International journal of molecular sciences.

[62]  Y. Zhang,et al.  Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer , 2022, Frontiers in Immunology.

[63]  James E. Dahlman,et al.  Drug delivery systems for RNA therapeutics , 2022, Nature Reviews Genetics.

[64]  J. Kjems,et al.  The emerging roles of circRNAs in cancer and oncology , 2021, Nature Reviews Clinical Oncology.

[65]  Rui Wang,et al.  The Molecular Roles and Clinical Implications of Non-Coding RNAs in Gastric Cancer , 2021, Frontiers in Cell and Developmental Biology.

[66]  A. Ismail,et al.  A review of the biological role of miRNAs in prostate cancer suppression and progression. , 2021, International journal of biological macromolecules.

[67]  P. Putora,et al.  Metastatic Prostate Cancer: Treatment Options , 2021, Oncology.

[68]  Y. Cai,et al.  Down‐regulated LINC00115 inhibits prostate cancer cell proliferation and invasion via targeting miR‐212‐5p/FZD5/Wnt/β‐catenin axis , 2021, Journal of cellular and molecular medicine.

[69]  F. Demichelis,et al.  Circulating RNAs in prostate cancer patients. , 2021, Cancer letters.

[70]  Qi Chen,et al.  Wnt/β-catenin signal transduction pathway in prostate cancer and associated drug resistance , 2021, Discover Oncology.

[71]  R. Bristow,et al.  Prostate cancer , 2021, The Lancet.

[72]  Longlong Zhang,et al.  PHLDA3 exerts an antitumor function in prostate cancer by down-regulating Wnt/β-catenin pathway via inhibition of Akt. , 2021, Biochemical and biophysical research communications.

[73]  Yajun Liu,et al.  AGAP2-AS1/miR-628-5p/FOXP2 feedback loop facilitates the growth of prostate cancer via activating WNT pathway. , 2021, Carcinogenesis.

[74]  C. Maher,et al.  Long noncoding RNAs in cancer metastasis , 2021, Nature Reviews Cancer.

[75]  Pengcheng Bu,et al.  Non-coding RNA in cancer , 2021, Essays in biochemistry.

[76]  R. Pettigrew,et al.  The Limitless Future of RNA Therapeutics , 2021, Frontiers in Bioengineering and Biotechnology.

[77]  T. H. van der Kwast,et al.  Prostate cancer , 2021, Nature Reviews Disease Primers.

[78]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[79]  G. Meister,et al.  siRNA Specificity: RNAi Mechanisms and Strategies to Reduce Off-Target Effects , 2021, Frontiers in Plant Science.

[80]  Xiao-ming Meng,et al.  Advancement and properties of circular RNAs in prostate cancer: An emerging and compelling frontier for discovering , 2021, International journal of biological sciences.

[81]  C. Croce,et al.  MicroRNA and ER stress in cancer. , 2021, Seminars in cancer biology.

[82]  Xiaodong Wang,et al.  The function of long noncoding RNA HOTAIRM1 in the progression of prostate cancer cells , 2020, Andrologia.

[83]  Maite Huarte,et al.  Gene regulation by long non-coding RNAs and its biological functions , 2020, Nature reviews. Molecular cell biology.

[84]  Ya Zhang,et al.  Targeting the Wnt/β-catenin signaling pathway in cancer , 2020, Journal of Hematology & Oncology.

[85]  Xiukun Lin,et al.  Cucurbitacin Mediated Regulation of Deregulated Oncogenic Signaling Cascades and Non-coding RNAs in Different Cancers: Spotlight on JAK/STAT, Wnt/β-catenin, mTOR, TRAIL-mediated pathways. , 2020, Seminars in cancer biology.

[86]  G. Scagliotti,et al.  Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications. , 2020, Critical reviews in oncology/hematology.

[87]  R. Xu,et al.  LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer , 2020, Cancer communications.

[88]  Guo Ziqi,et al.  The roles of miRNA, lncRNA and circRNA in the development of osteoporosis , 2020, Biological research.

[89]  S. Pai,et al.  Cellular and Molecular Progression of Prostate Cancer: Models for Basic and Preclinical Research , 2020, Cancers.

[90]  Jun Luo,et al.  Crosstalk Between AR and Wnt Signaling Promotes Castration-Resistant Prostate Cancer Growth , 2020, OncoTargets and therapy.

[91]  Xinna Deng,et al.  Circular RNA cir-ITCH Is a Potential Therapeutic Target for the Treatment of Castration-Resistant Prostate Cancer , 2020, BioMed research international.

[92]  N. Jha,et al.  Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics. , 2020, Chemico-biological interactions.

[93]  G. Xu,et al.  MiR-34a affects G2 arrest in prostate cancer PC3 cells via Wnt pathway and inhibits cell growth and migration. , 2020, European review for medical and pharmacological sciences.

[94]  M. Czyz,et al.  WNT Signaling in Melanoma , 2020, International journal of molecular sciences.

[95]  T. Chong,et al.  TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway , 2020, Anti-cancer drugs.

[96]  B. Vick,et al.  Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia. , 2020, Cancer cell.

[97]  C. Na,et al.  GDE2-Dependent Activation of Canonical Wnt Signaling in Neurons Regulates Oligodendrocyte Maturation , 2020, Cell reports.

[98]  Ming-hua Bai,et al.  Long Non-coding RNA SNHG17 Promotes Cell Proliferation and Invasion in Castration-Resistant Prostate Cancer by Targeting the miR-144/CD51 Axis , 2020, Frontiers in Genetics.

[99]  N. Rezaei,et al.  Expression level of long noncoding RNA NKILAmiR103-miR107 inflammatory axis and its clinical significance as potential biomarker in patients with colorectal cancer , 2020, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[100]  P. Choyke,et al.  MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis. , 2020, The New England journal of medicine.

[101]  Xiaosong Sun,et al.  Knockdown of lncRNA TUG1 Enhances Radiosensitivity of Prostate Cancer via the TUG1/miR-139-5p/SMC1A Axis , 2020, OncoTargets and therapy.

[102]  Long Lin,et al.  LncRNA625 inhibits STAT1-mediated transactivation potential in esophageal cancer cells. , 2019, The international journal of biochemistry & cell biology.

[103]  Fan Yang,et al.  SOX30, a target gene of miR-653-5p, represses the proliferation and invasion of prostate cancer cells through inhibition of Wnt/β-catenin signaling , 2019, Cellular & Molecular Biology Letters.

[104]  C. Collins,et al.  The evolution of long noncoding RNA acceptance in prostate cancer initiation and progression, and its clinical utility in disease management. , 2019, European urology.

[105]  X. Ke,et al.  WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment , 2019, Front. Immunol..

[106]  D. Chellappan,et al.  Emerging trends in the novel drug delivery approaches for the treatment of lung cancer. , 2019, Chemico-biological interactions.

[107]  Yin Liu,et al.  miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway , 2019, Journal of Biosciences.

[108]  Peijing Zhang,et al.  Non-Coding RNAs and their Integrated Networks , 2019, J. Integr. Bioinform..

[109]  W. Xiong,et al.  Knockdown of the long noncoding RNA HOTTIP inhibits cell proliferation and enhances cell sensitivity to cisplatin by suppressing the Wnt/β‐catenin pathway in prostate cancer , 2019, Journal of cellular biochemistry.

[110]  Prashanth Rawla,et al.  Epidemiology of Prostate Cancer , 2019, World journal of oncology.

[111]  Annette Fenner.  Prostate cancer: a tale of two sides , 2019, Nature Reviews Urology.

[112]  S. Ghorbian,et al.  Long non-coding RNAs and cervical cancer. , 2019, Experimental and molecular pathology.

[113]  P. Kantoff,et al.  Treatment of Advanced Prostate Cancer. , 2019, Annual review of medicine.

[114]  G. Gupta,et al.  MicroRNAs as biological regulators in skin disorders. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[115]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[116]  P. Wei,et al.  The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5 , 2018, Journal of Hematology & Oncology.

[117]  D. Margolis,et al.  MRI‐Targeted or Standard Biopsy for Prostate‐Cancer Diagnosis , 2018, The New England journal of medicine.

[118]  Hyeon Jeong Lee,et al.  Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/β-catenin Pathway , 2018, Molecular Cancer Research.

[119]  O. Slabý,et al.  Therapeutic targeting of non-coding RNAs in cancer. , 2017, The Biochemical journal.

[120]  P. Khavari,et al.  The functions and unique features of long intergenic non-coding RNA , 2017, Nature Reviews Molecular Cell Biology.

[121]  R. Nusse,et al.  Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities , 2017, Cell.

[122]  Y-H Zhang,et al.  LncRNA625 modulates prostate cancer cells proliferation and apoptosis through regulating the Wnt/β-catenin pathway by targeting miR-432. , 2017, European review for medical and pharmacological sciences.

[123]  Jiateng Zhong,et al.  Inhibition of DIXDC1 by microRNA-1271 suppresses the proliferation and invasion of prostate cancer cells. , 2017, Biochemical and biophysical research communications.

[124]  S. Logan,et al.  Revisiting the role of Wnt/β-catenin signaling in prostate cancer , 2017, Molecular and Cellular Endocrinology.

[125]  Yeqing Huang,et al.  MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling , 2017, Oncotarget.

[126]  Xuan Liang,et al.  MicroRNA-1297 inhibits prostate cancer cell proliferation and invasion by targeting the AEG-1/Wnt signaling pathway. , 2016, Biochemical and biophysical research communications.

[127]  Zhenpeng Qiu,et al.  Methylated urolithin A, the modified ellagitannin-derived metabolite, suppresses cell viability of DU145 human prostate cancer cells via targeting miR-21. , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[128]  A. Hamid,et al.  The Risk Factors of Prostate Cancer and Its Prevention: A Literature Review. , 2016, Acta medica Indonesiana.

[129]  Zhankui Jia,et al.  MiR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression. , 2016, Oncology reports.

[130]  F. Feng,et al.  Long noncoding RNAs in prostate cancer: overview and clinical implications , 2016, Asian journal of andrology.

[131]  M. Mlodzik,et al.  Wnt-Frizzled/planar cell polarity signaling: cellular orientation by facing the wind (Wnt). , 2015, Annual review of cell and developmental biology.

[132]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[133]  Hongsheng Wang,et al.  FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells. , 2015, Cellular signalling.

[134]  J. Mott,et al.  Overview of MicroRNA Biology , 2015, Seminars in Liver Disease.

[135]  A. D. De Marzo,et al.  LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a , 2015, Molecular Cancer Research.

[136]  G. Calin,et al.  NCRNA combined therapy as future treatment option for cancer. , 2014, Current pharmaceutical design.

[137]  Wei-Yu Chen,et al.  MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer , 2014, Oncotarget.

[138]  Timothy J Wilt,et al.  Prevention and early detection of prostate cancer. , 2014, The Lancet. Oncology.

[139]  V. Bajic,et al.  On the classification of long non-coding RNAs , 2013, RNA biology.

[140]  Sangtaek Oh,et al.  Clinical Significance of Wnt/β-Catenin Signalling and Androgen Receptor Expression in Prostate Cancer , 2013, The world journal of men's health.

[141]  R. Dahiya,et al.  Genistein Up-Regulates Tumor Suppressor MicroRNA-574-3p in Prostate Cancer , 2013, PloS one.

[142]  T. Hong,et al.  MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. , 2013, Carcinogenesis.

[143]  Sebastian D. Mackowiak,et al.  Circular RNAs are a large class of animal RNAs with regulatory potency , 2013, Nature.

[144]  C. Porto,et al.  Physiopathological aspects of the Wnt/β-catenin signaling pathway in the male reproductive system , 2013, Spermatogenesis.

[145]  J. Waxman,et al.  Wnt/β-catenin signalling in prostate cancer , 2012, Nature Reviews Urology.

[146]  S. Tabatabaei,et al.  Prostate cancer imaging: what surgeons, radiation oncologists, and medical oncologists want to know. , 2011, AJR. American journal of roentgenology.

[147]  B. Williams,et al.  Wnt/β-catenin Signaling in Normal and Cancer Stem Cells , 2011, Cancers.

[148]  K. Garber.  A tale of two cells: discovering the origin of prostate cancer. , 2010, Journal of the National Cancer Institute.

[149]  Xin Wang,et al.  Role of Wnt canonical pathway in hematological malignancies , 2010, Journal of hematology & oncology.

[150]  Christof Niehrs,et al.  Regulation of Lrp6 phosphorylation , 2010, Cellular and Molecular Life Sciences.

[151]  A. Levine,et al.  Ribosome‐inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase‐1 selectively in premalignant and malignant prostate cancer cells , 2009, International journal of cancer.

[152]  Xi He,et al.  Wnt/beta-catenin signaling: components, mechanisms, and diseases. , 2009, Developmental cell.

[153]  Li Ma,et al.  Mitogen-activated Protein Kinase p38 Regulates the Wnt/Cyclic GMP/Ca2+ Non-canonical Pathway* , 2007, Journal of Biological Chemistry.

[154]  Anthony M. C. Brown,et al.  Canonical Wnt signaling: high-throughput RNAi widens the path , 2005, Genome Biology.

[155]  T. Tuschl,et al.  Identification of Novel Genes Coding for Small Expressed RNAs , 2001, Science.

[156]  Harold E. Varmus,et al.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome , 1982, Cell.

[157]  D. Kolakofsky.  Isolation and characterization of Sendai virus DI-RNAs , 1976, Cell.

[158]  Shu Yang,et al.  Wnt/Beta-Catenin Signaling and Prostate Cancer Therapy Resistance. , 2019, Advances in experimental medicine and biology.

[159]  D. Chellappan,et al.  Role of the Tristetraprolin (Zinc Finger Protein 36 Homolog) Gene in Cancer. , 2018, Critical reviews in eukaryotic gene expression.

[160]  A. Morillon,et al.  History, Discovery, and Classification of lncRNAs. , 2017, Advances in experimental medicine and biology.

[161]  G. Zaman,et al.  New avenues to target Wnt/β-catenin signaling. , 2011, Drug discovery today.